Clinical Trials Browser

mirdametinib × Other solid neoplasm × Clear all

NCT05580770 2025-02-17

Mirdametinib + BGB-3245 in Advanced Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Advanced Solid Tumor

NCT02022982 2024-03-19

PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors

Phase 1 Completed

Other solid neoplasmThoracic

KRAS Mutant Non-Small Cell Lung Cancer